Synthetic cannabinoids was used to induce mitochondrial-mediated apoptotic and autophagy pathways in human LN18, T98G, and U251MG glioblastoma cells deficient in TP53 or PTEN tumor suppressors (Ellert-Miklaszewska et al., 2021). The gene discussed is TP53; the disease is glioblastoma.